Public reporting of the hospital standardized mortality ratio (HSMR): implications for the Canadian approach to safety and quality in health care

por Brien, Susan E, Ghali, William A
Publicado 2008

Is a BTKi or BCL2i preferable for first “novel” therapy in CLL? The case for BTKis

por Brem, Elizabeth A., O’Brien, Susan
Publicado 2022

Critical appraisal of the role of rituximab in the treatment of patients with previously untreated or treated chronic lymphocytic leukemia (CLL)

por Al-Kali, Aref, Wierda, William, Keating, Michael, O’Brien, Susan
Publicado 2010

Cellular Therapies in Chronic Lymphocytic Leukemia and Richter’s Transformation: Recent Developments in Chimeric Antigen Receptor T-Cells, Natural Killer Cells, and Allogeneic Stem...

por Coombs, Catherine C., Easaw, Saumya, Grover, Natalie S., O’Brien, Susan M.
Publicado 2023

Overview of a formal scoping review on health system report cards

por Brien, Susan E, Lorenzetti, Diane L, Lewis, Steven, Kennedy, James, Ghali, William A
Publicado 2010

Exploring the components of physician volunteer engagement: a qualitative investigation of a national Canadian simulation-based training programme

por Sarti, Aimee J, Sutherland, Stephanie, Landriault, Angele, DesRosier, Kirk, Brien, Susan, Cardinal, Pierre
Publicado 2017

Understanding of evaluation capacity building in practice: a case study of a national medical education organization

por Sarti, Aimee J, Sutherland, Stephanie, Landriault, Angele, DesRosier, Kirk, Brien, Susan, Cardinal, Pierre
Publicado 2017

Association of alcohol consumption with selected cardiovascular disease outcomes: a systematic review and meta-analysis

por Ronksley, Paul E, Brien, Susan E, Turner, Barbara J, Mukamal, Kenneth J, Ghali, William A
Publicado 2011

Effect of alcohol consumption on biological markers associated with risk of coronary heart disease: systematic review and meta-analysis of interventional studies

por Brien, Susan E, Ronksley, Paul E, Turner, Barbara J, Mukamal, Kenneth J, Ghali, William A
Publicado 2011

Clinical Perspectives on the Molecular and Pharmacological Attributes of Anti-CD20 Therapies for Multiple Sclerosis

por Bar-Or, Amit, O’Brien, Susan M., Sweeney, Michael L., Fox, Edward J., Cohen, Jeffrey A.
Publicado 2021

Rituximab in B-Cell Hematologic Malignancies: A Review of 20 Years of Clinical Experience

por Salles, Gilles, Barrett, Martin, Foà, Robin, Maurer, Joerg, O’Brien, Susan, Valente, Nancy, Wenger, Michael, Maloney, David G.
Publicado 2017

Monitoring and Managing BTK Inhibitor Treatment-Related Adverse Events in Clinical Practice

por O’Brien, Susan M., Brown, Jennifer R., Byrd, John C., Furman, Richard R., Ghia, Paolo, Sharman, Jeff P., Wierda, William G.
Publicado 2021

P640: ZANUBRUTINIB VS IBRUTINIB IN RELAPSED/REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA AND SMALL LYMPHOCYTIC LYMPHOMA (R/R CLL/SLL): IMPACT ON HEALTH-RELATED QUALITY OF LIFE (HRQOL)

por Eichhorst, Barbara, Lamanna, Nicole, O’brien, Susan, Tam, Constantine, Qiu, Lugui, Yang, Keri, Wu, Ken, Salmi, Tommi, Barnes, Gisoo, Brown, Jennifer R.
Publicado 2023

Mapping the Expert Mind: Integration Method for Revising the ACES Medical Simulation Curriculum

por Cardinal, Pierre, Barton, Glenn, DesRosier, Kirk, Yamashita, Sharon, Landriault, Angèle, Sarti, Aimee, Sutherland, Stephanie, Brien, Susan, McCarragher, Kevin, Witter, Tobias
Publicado 2020

JAK2 Exon 14 Deletion in Patients with Chronic Myeloproliferative Neoplasms

por Ma, Wanlong, Kantarjian, Hagop, Zhang, Xi, Wang, Xiuqiang, Zhang, Zhong, Yeh, Chen-Hsiung, O'Brien, Susan, Giles, Francis, Bruey, Jean Marie, Albitar, Maher
Publicado 2010

Long‐term efficacy of first‐line ibrutinib treatment for chronic lymphocytic leukaemia in patients with TP53 aberrations: a pooled analysis from four clinical trials

por Allan, John N., Shanafelt, Tait, Wiestner, Adrian, Moreno, Carol, O’Brien, Susan M., Li, Jianling, Krigsfeld, Gabriel, Dean, James P., Ahn, Inhye E.
Publicado 2021

"Sleepiness" is serious in adolescence: Two surveys of 3235 Canadian students

por Gibson, Edward S, Powles, AC Peter, Thabane, Lehana, O'Brien, Susan, Molnar, Danielle Sirriani, Trajanovic, Nik, Ogilvie, Robert, Shapiro, Colin, Yan, Mi, Chilcott-Tanser, Lisa
Publicado 2006

Phase II, Open Label, Randomized Comparative Trial of Ondansetron Alone versus the Combination of Ondansetron and Aprepitant for the Prevention of Nausea and Vomiting in Patients w...

por Badar, Talha, Cortes, Jorge, Borthakur, Gautam, O'Brien, Susan, Wierda, William, Garcia-Manero, Guillermo, Ferrajoli, Alessandra, Kadia, Tapan, Poku, Rebeca, Kantarjian, Hagop, Mattiuzzi, Gloria
Publicado 2015

Optimal Management of Adverse Events From Copanlisib in the Treatment of Patients With Non-Hodgkin Lymphomas

por Cheson, Bruce D., O’Brien, Susan, Ewer, Michael S., Goncalves, Marcus D., Farooki, Azeez, Lenz, Georg, Yu, Anthony, Fisher, Richard I., Zinzani, Pierre L., Dreyling, Martin
Publicado 2018

Improving the quality of person-centred healthcare from the patient perspective: development of person-centred quality indicators

por Santana, Maria-Jose, Manalili, Kimberly, Zelinsky, Sandra, Brien, Susan, Gibbons, Elizabeth, King, Jenny, Frank, Lori, Wallström, Sara, Fairie, Paul, Leeb, Kira, Quan, Hude, Sawatzky, Richard
Publicado 2020